Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Sarcoma 2CNS 1

Conditions

Uterine Cervical Neoplasms 2Vaginal Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1

Interventions

Paclitaxel 37Bevacizumab 34Carboplatin 30pembrolizumab 25Specimen Handling 21Magnetic Resonance Spectroscopy 19olaparib 18Cisplatin 15liposomal doxorubicin 13Taxes 13Immunoglobulin G 12Gemcitabine 12Disulfides 12Topotecan 9Nivolumab 9Cyclophosphamide 9Biopsy 9mirvetuximab soravtansine 7Doxorubicin 7fludarabine 6Radiation 6Fulvestrant 6niraparib 5durvalumab 5cediranib 5atezolizumab 5Platinum 5Oxaliplatin 5Fluorouracil 51,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Congresses as Topic × Gynecologic × 30 days × Clear all
NCT02466971 2026-06-15

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT07061977 2026-06-15

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

NCT02595879 2026-05-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled 22 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡